↓ Skip to main content

Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus

Overview of attention for article published in Cochrane database of systematic reviews, April 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
49 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
245 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
Published in
Cochrane database of systematic reviews, April 2019
DOI 10.1002/14651858.cd012368.pub2
Pubmed ID
Authors

Kasper S Madsen, Pernille Kähler, Lise Katrine Aronsen Kähler, Sten Madsbad, Filip Gnesin, Maria-Inti Metzendorf, Bernd Richter, Bianca Hemmingsen

Twitter Demographics

The data shown below were collected from the profiles of 49 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 245 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 245 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 48 20%
Student > Bachelor 27 11%
Researcher 26 11%
Student > Postgraduate 18 7%
Student > Ph. D. Student 18 7%
Other 48 20%
Unknown 60 24%
Readers by discipline Count As %
Medicine and Dentistry 84 34%
Nursing and Health Professions 32 13%
Biochemistry, Genetics and Molecular Biology 10 4%
Pharmacology, Toxicology and Pharmaceutical Science 9 4%
Social Sciences 7 3%
Other 33 13%
Unknown 70 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 34. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2021.
All research outputs
#724,905
of 17,373,814 outputs
Outputs from Cochrane database of systematic reviews
#1,848
of 11,662 outputs
Outputs of similar age
#20,004
of 276,036 outputs
Outputs of similar age from Cochrane database of systematic reviews
#12
of 21 outputs
Altmetric has tracked 17,373,814 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,662 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.0. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 276,036 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.